RESEARCH


 

Microcurrent electrotherapy (MCT) delivers gentle, sub-sensory electrical currents that precisely mirror the body's own bioelectrical signals. Backed by a growing body of independent clinical research, MCT has proven effective in managing pain, accelerating wound healing, alleviating chronic fatigue, supporting fibromyalgia treatment, and improving mood disorders. These are the very conditions that KFH devices are expertly designed to address, offering you a scientifically supported path to better health.

Regulatory Classification & Clearances

  • US: Class II under FDA regulation 21 CFR 882.5890 (Transcutaneous Electrical Nerve Stimulator for Pain Relief). KFH Energy (Model E1) received FDA 510(k) clearance as substantially equivalent (510(k) Number: K073008; FDA Listing Number: D044825; Cleared: March 11, 2008).
  • EU: Class IIa, Type B medical devices under Medical Device Directive (MDD 93/42/EEC).

KFH Energy and KFH Novo are designed for safe, non-invasive use but should be used under professional guidance.

 

Research Pipeline

Overview of independent clinical research stages per therapeutic area.

Study & Indication Device Feasibility Controlled Study RCT Status
METIPP — Post-Polio Syndrome (fatigue, endurance, pain) KFH Energy ✓ ✓ ✓ Published
BESTIMS — Multiple Sclerosis (fatigue, mobility) KFH Energy ✓ ✓ — Published
DOMS — Exercise Recovery (muscle soreness) KFH Energy ✓ ✓ ✓ Published
ULTRA-BEST — Chronic Venous Ulcers (wound healing) KFH Novo ✓ ✓ — Published


Our Clinical Research Pipeline

KFH ENERGY

METIPP Clinical Study – Post-Polio Syndrome (PPS)
  • Study focused on fatigue reduction in PPS patients, where over 85% experience paralyzing fatigue due to altered muscle fiber composition and energy imbalances.
  • Results:
    • 34% consistent and statistically significant reduction in total fatigue score
    • 40% increase in endurance; 4 in 5 patients showed measurable progress
    • 34% reduction in total pain score; 7 out of 10 patients observed improvement
  • Institution: Hasselt University
METIPP study: Brief Fatigue Inventory results showing 34% reduction in total fatigue scoreMETIPP study: 40% increase in endurance, with 4 in 5 patients showing measurable progressMETIPP study: 34% reduction in total pain score, with 7 in 10 patients showing improvement
METIPP study results — fatigue, endurance, and pain. Hasselt University. 
BESTIMS Clinical Study – Multiple Sclerosis (MS)
  • Investigated MCT therapy effectiveness in helping MS patients maintain mobility and reduce fatigue despite no change in muscle strength.
  • Results: MS patients experienced decreased fatigue and increased stamina.
  • Institution: Hasselt University
DOMS Clinical Study – Athletic Recovery
  • Double-blind, placebo-controlled study with 16 healthy male volunteers (18–25 years, BMI ~25) examining recovery from intense eccentric exercise.
  • Results:
    • Muscle strength recovery was 2× faster with MCT than placebo (p < 0.05)
    • Pain and CK concentration were consistently much lower in the MCT group
    • Significant muscle soreness reduction and faster tissue recovery
  • Institution: University of Hasselt
DOMS study: muscle torque (strength) recovery — MCT vs placeboDOMS study: VAS pain scores over recovery period — MCT vs placeboDOMS study: serum creatine kinase concentration (muscle damage marker) — MCT vs placeboDOMS study: muscle perimeter (swelling) over recovery period — MCT vs placebo
DOMS study data — muscle torque, pain (VAS), creatine kinase, muscle perimeter. University of Hasselt. 

KFH NOVO

ULTRA-BEST Clinical Study – Chronic Venous Ulcers
  • Multi-center research examining MCT therapy's efficacy in chronic wound healing and venous ulcer treatment.
  • Participating centers: UZ Gasthuisberg, UZ Brussel, Virga Jesse Hospital Hasselt, CHU Liège, UZ Gent
  • Supporting evidence: Multiple case studies demonstrating healing efficacy

 

 

For more information about KFHealth research, contact: research@kfhealth.eu

 

SHOP NOW

 

Note: The clinical research described on this page was conducted on KFH devices in collaboration with the named institutions. Results are summarised here for informational purposes and do not constitute medical advice. Always consult a qualified healthcare professional before starting any treatment.